Johnson & Johnson has filed for US approval for a new claim on the label for its nasal spray antidepressant Spravato showing that it can help prevent suicide in at-risk patients.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,